SMFM Statement: Clarification of recommendations regarding cell-free DNA aneuploidy screening

American Journal of Obstetrics and Gynecology

Volumn 213, Issue 6, 2015, Pages 753-754

[No Author Info available]

Author keywords

cell free DNA aneuploidy screening; diagnostic testing; genetic testing; prenatal aneuploidy screening

Indexed keywords

DNA;

ANEUPLOIDY; ARTICLE; CELL FREE SYSTEM; COST EFFECTIVENESS ANALYSIS; DNA SCREENING; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE ORGANIZATION; HUMAN; LOW RISK POPULATION; MEDICAL DOCUMENTATION; MEDICAL ETHICS; PATIENT EDUCATION; PRACTICE GUIDELINE; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCREENING TEST; BLOOD; DOCUMENTATION; FEMALE; HIGH RISK PREGNANCY; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

ANEUPLOIDY; CELL-FREE SYSTEM; DNA; DOCUMENTATION; FEMALE; GENETIC TESTING; HUMANS; PREGNANCY; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS;

EID: 84962292458     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.09.077     Document Type: Article

References (5)

1. Society for Maternal-Fetal Medicine (SMFM) Publications Committee Prenatal aneuploidy screening using cell-free DNA. Consult series no. 36 Am J Obstet Gynecol 212 2015 711 716
2. Cell-free DNA screening for fetal aneuploidy. Committee opinion no. 640 Obstet Gynecol 126 2015 691 692
3. American College of Obstetricians and Gynecologists Invasive prenatal testing for aneuploidy. ACOG Practice bulletin no. 88 Obstet Gynecol 110 2007 1459 1467
4. A.J. Kaimal, M.E. Norton, and M. Kuppermann Prenatal testing in the genomic age: clinical outcomes, quality of life, and costs Obstet Gynecol 126 2015 1 11
5. Daley B; New England Center for Investigative Reporting. Oversold prenatal tests spur some to choose abortions. Boston Globe Dec. 14, 2014. Available at: https://www.bostonglobe.com/metro/2014/12/14/oversold-and-unregulated-flawed-prenatal-tests-leading-abortions-healthy-fetuses/aKFAOCP5N0Kr8S1HirL7EN/story.html. Accessed October 13, 2015.